No Data
No Data
Expert Ratings For RadNet
4 analysts have shared their evaluations of RadNet (NASDAQ:RDNT) during the recent three months, expressing a mix of bullish and bearish perspectives.The table below summarizes their recent ratings,
RadNet Is Maintained at Buy by Jefferies
RadNet Is Maintained at Buy by
Jefferies Maintains RadNet(RDNT.US) With Buy Rating, Raises Target Price to $75
Jefferies analyst Brian Tanquilut maintains $RadNet(RDNT.US)$ with a buy rating, and adjusts the target price from $61 to $75.According to TipRanks data, the analyst has a success rate of 48.8% and
Analysts Conflicted on These Healthcare Names: Amylyx Pharmaceuticals Inc (AMLX), Centene (CNC) and Radnet (RDNT)
Express News | RadNet Inc : Jefferies Raises Target Price to $75 From $61
RadNet Is Maintained at Equal-Weight by Barclays
RadNet Is Maintained at Equal-Weight by
No Data